Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study
Safarinejad MR
Published in International Journal of Impotence Research
Key Findings
In patients with early chronic PD, CoQ10 therapy leads plaque size and penile curvature reduction and improves EF. Note: other Peyronie's trials by this investigator have been retracted or flagged, so this result should be treated with caution.
Conclusions
In patients with early chronic PD, CoQ10 therapy leads plaque size and penile curvature reduction and improves EF. Note: other Peyronie's trials by this investigator have been retracted or flagged, so this result should be treated with caution.
Supplements Studied
In patients with early chronic PD, CoQ10 therapy leads plaque size and penile curvature reduction and improves EF. Note: other Peyronie's trials by this investigator have been retracted or flagged, so this result should be treated with caution.
Outcomes Measured
In patients with early chronic PD, CoQ10 therapy leads plaque size and penile curvature reduction and improves EF. Note: other Peyronie's trials by this investigator have been retracted or flagged, so this result should be treated with caution.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.